June 12, 2009 - NanoScan Imaging LLC today announced the publication of new data demonstrating the use of its investigational, radio-opaque contrast agent (N1177) to visualize vulnerable plaques that can cause heart attack or stroke using advanced, noninvasive and high-resolution computed tomography (CT) techniques.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now